Xenetic Biosciences (XBIO) Competitors $2.38 -0.03 (-1.08%) Closing price 04/17/2025 03:59 PM EasternExtended Trading$2.44 +0.06 (+2.31%) As of 04/17/2025 04:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsOwnershipSEC FilingsShort InterestTrendsBuy This Stock XBIO vs. GOVX, NRSN, GLYC, IPA, BOLT, LPTX, CLRB, COCP, ME, and SPRBShould you be buying Xenetic Biosciences stock or one of its competitors? The main competitors of Xenetic Biosciences include GeoVax Labs (GOVX), NeuroSense Therapeutics (NRSN), GlycoMimetics (GLYC), ImmunoPrecise Antibodies (IPA), Bolt Biotherapeutics (BOLT), Leap Therapeutics (LPTX), Cellectar Biosciences (CLRB), Cocrystal Pharma (COCP), 23andMe (ME), and Spruce Biosciences (SPRB). These companies are all part of the "pharmaceutical preparations" industry. Xenetic Biosciences vs. GeoVax Labs NeuroSense Therapeutics GlycoMimetics ImmunoPrecise Antibodies Bolt Biotherapeutics Leap Therapeutics Cellectar Biosciences Cocrystal Pharma 23andMe Spruce Biosciences GeoVax Labs (NASDAQ:GOVX) and Xenetic Biosciences (NASDAQ:XBIO) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, institutional ownership, risk, profitability, community ranking and earnings. Does the media prefer GOVX or XBIO? In the previous week, GeoVax Labs had 11 more articles in the media than Xenetic Biosciences. MarketBeat recorded 12 mentions for GeoVax Labs and 1 mentions for Xenetic Biosciences. Xenetic Biosciences' average media sentiment score of 0.33 beat GeoVax Labs' score of -0.05 indicating that Xenetic Biosciences is being referred to more favorably in the news media. Company Overall Sentiment GeoVax Labs Neutral Xenetic Biosciences Neutral Do insiders and institutionals hold more shares of GOVX or XBIO? 6.1% of GeoVax Labs shares are owned by institutional investors. Comparatively, 15.1% of Xenetic Biosciences shares are owned by institutional investors. 5.7% of GeoVax Labs shares are owned by insiders. Comparatively, 14.7% of Xenetic Biosciences shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has more risk and volatility, GOVX or XBIO? GeoVax Labs has a beta of 3.7, suggesting that its share price is 270% more volatile than the S&P 500. Comparatively, Xenetic Biosciences has a beta of 2.3, suggesting that its share price is 130% more volatile than the S&P 500. Is GOVX or XBIO more profitable? GeoVax Labs has a net margin of 0.00% compared to Xenetic Biosciences' net margin of -161.63%. Xenetic Biosciences' return on equity of -49.51% beat GeoVax Labs' return on equity.Company Net Margins Return on Equity Return on Assets GeoVax LabsN/A -809.87% -349.34% Xenetic Biosciences -161.63%-49.51%-43.99% Which has stronger earnings and valuation, GOVX or XBIO? Xenetic Biosciences has lower revenue, but higher earnings than GeoVax Labs. Xenetic Biosciences is trading at a lower price-to-earnings ratio than GeoVax Labs, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGeoVax Labs$3.95M2.90-$25.97M-$5.67-0.15Xenetic Biosciences$2.50M1.47-$4.14M-$2.57-0.93 Do analysts prefer GOVX or XBIO? GeoVax Labs currently has a consensus price target of $12.90, suggesting a potential upside of 1,455.15%. Given GeoVax Labs' stronger consensus rating and higher possible upside, analysts plainly believe GeoVax Labs is more favorable than Xenetic Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score GeoVax Labs 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 2 Strong Buy rating(s) 3.29Xenetic Biosciences 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the MarketBeat Community believe in GOVX or XBIO? Xenetic Biosciences received 145 more outperform votes than GeoVax Labs when rated by MarketBeat users. However, 96.67% of users gave GeoVax Labs an outperform vote while only 66.92% of users gave Xenetic Biosciences an outperform vote. CompanyUnderperformOutperformGeoVax LabsOutperform Votes2996.67% Underperform Votes13.33%Xenetic BiosciencesOutperform Votes17466.92% Underperform Votes8633.08% SummaryGeoVax Labs beats Xenetic Biosciences on 11 of the 19 factors compared between the two stocks. Get Xenetic Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for XBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart XBIO vs. The Competition Export to ExcelMetricXenetic BiosciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.68M$6.45B$5.30B$7.35BDividend YieldN/A3.23%5.12%4.30%P/E Ratio-0.906.8921.8017.80Price / Sales1.47231.03379.9697.74Price / CashN/A65.6738.2634.64Price / Book0.375.936.443.98Net Income-$4.14M$142.99M$3.21B$247.73M7 Day Performance3.65%4.43%2.88%1.81%1 Month Performance-31.10%-12.73%-8.63%-6.98%1 Year Performance-40.40%-9.47%11.46%1.29% Xenetic Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)XBIOXenetic Biosciences1.3966 of 5 stars$2.38-1.1%N/A-38.2%$3.68M$2.50M-0.904Short Interest ↓GOVXGeoVax Labs2.3206 of 5 stars$1.07+4.9%$14.20+1,227.1%-43.2%$14.81M$3.95M-0.1910Analyst ForecastShort Interest ↑Analyst RevisionNRSNNeuroSense Therapeutics0.4648 of 5 stars$1.08+1.9%N/A-35.4%$14.76MN/A-1.6910Short Interest ↑GLYCGlycoMimetics1.1861 of 5 stars$0.22+10.0%N/A-90.2%$14.32M$10,000.000.0050Analyst ForecastIPAImmunoPrecise Antibodies2.7068 of 5 stars$0.46+6.0%$4.00+775.1%-65.5%$14.20M$24.00M-0.5980Short Interest ↓Gap DownBOLTBolt Biotherapeutics2.522 of 5 stars$0.37+14.3%$1.13+204.1%-68.5%$14.19M$7.69M-0.2290Negative NewsGap UpLPTXLeap Therapeutics1.5538 of 5 stars$0.34+5.2%$4.92+1,341.8%-87.9%$14.07MN/A-0.1840Short Interest ↑Gap DownCLRBCellectar Biosciences2.2557 of 5 stars$0.29+5.5%$12.50+4,144.5%-90.7%$13.57MN/A-0.1710Short Interest ↓News CoverageCOCPCocrystal Pharma1.9948 of 5 stars$1.33+3.9%$7.00+426.3%-8.0%$13.53MN/A-0.7210Gap DownME23andMe0.4227 of 5 stars$0.50-35.3%$9.40+1,787.6%-93.0%$13.36M$208.78M-0.03770Gap DownHigh Trading VolumeSPRBSpruce Biosciences2.5925 of 5 stars$0.31+8.0%$2.50+695.2%-83.2%$12.99M$7.10M-0.3320Earnings ReportAnalyst ForecastShort Interest ↓Analyst RevisionNews CoveragePositive NewsGap Up Related Companies and Tools Related Companies GOVX Competitors NRSN Competitors GLYC Competitors IPA Competitors BOLT Competitors LPTX Competitors CLRB Competitors COCP Competitors ME Competitors SPRB Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:XBIO) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | Sponsored100-year-old investment secret predicts what?!A 100-year-old indicator has quietly predicted nearly every major market meltdown — including the Dot-Com Bust...Weiss Ratings | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xenetic Biosciences Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Xenetic Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy XBIO Stock Free XBIO Stock Alerts